<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39339978</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>23</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>N-Acetylcysteine Inhibits Coxsackievirus B3 Replication by Downregulating Eukaryotic Translation Elongation Factor 1 Alpha 1.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1503</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16091503</ELocationID><Abstract><AbstractText>Group B Coxsackieviruses (CVB) are one of the causative pathogens of myocarditis, which may progress to cardiomyopathy. The pathogenesis of CVB is not fully understood, and effective antiviral therapy is not available. N-acetylcysteine (NAC), the classic antioxidant, has been used in clinical practice for several decades to treat various medical conditions. In this study, the anti-CVB effect of NAC was investigated. We show that NAC dramatically suppressed viral replication and alleviated cardiac injury induced by CVB3. To further study the antiviral mechanism of NAC, RNA-sequencing was performed for CVB3-infected cells with NAC treatment. We found that eukaryotic elongation factor 1 alpha 1 (<i>EEF1A1</i>) is one of the most upregulated genes in CVB3-infected cells. However, <i>EEF1A2</i>, the highly homologous isoform of <i>EEF1A1</i>, remains unchanged. <i>EEF1A1</i> expression was significantly suppressed by NAC treatment in CVB3-infected cells, while <i>EEF1A2</i> was not affected. eEF1A1 knockdown significantly inhibited CVB3 replication, implicating that eEF1A1 facilitates viral replication. Importantly, we show that eEF1A1, which was not expressed in the myocardia of newborn mice, was significantly upregulated by CVB3 infection. NAC markedly downregulated the expression of eEF1A1 but not eEF1A2 in the myocardia of CVB3-infected mice. Furthermore, NAC accelerated eEF1A1 degradation by promoting autophagy in CVB3-infected cells. We show that p62, one of the critical adaptors of autophagic targets, interacts with eEF1A1 and was downregulated in CVB3-infected cells upon NAC treatment. Taken together, this study demonstrated that NAC shows a potent anti-CVB effect through the downregulation of eEF1A1.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yao</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0009-0006-4708-6018</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, 157 Baojian Road, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luan</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, 157 Baojian Road, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lixin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, 157 Baojian Road, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Danxiang</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, 157 Baojian Road, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Yanyan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, 157 Baojian Road, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Siwei</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0006-7891-6336</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, 157 Baojian Road, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, 157 Baojian Road, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, 157 Baojian Road, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fei</LastName><ForeName>Yanru</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, 157 Baojian Road, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Lexun</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, 157 Baojian Road, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Jiahui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, 157 Baojian Road, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Zhaohua</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-0778-5053</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, 157 Baojian Road, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Wenran</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, 157 Baojian Road, Harbin 150081, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>WYQ7N0BPYC</RegistryNumber><NameOfSubstance UI="D000111">Acetylcysteine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C094814">EEF1A1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020648">Peptide Elongation Factor 1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000111" MajorTopicYN="Y">Acetylcysteine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="Y">Down-Regulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="Y">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="N">Myocarditis</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020648" MajorTopicYN="Y">Peptide Elongation Factor 1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">N-acetylcysteine</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">coxsackievirus B</Keyword><Keyword MajorTopicYN="N">eukaryotic elongation factor 1 alpha 1</Keyword></KeywordList><CoiStatement>There are no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39339978</ArticleId><ArticleId IdType="pmc">PMC11437456</ArticleId><ArticleId IdType="doi">10.3390/v16091503</ArticleId><ArticleId IdType="pii">v16091503</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baggen J., Thibaut H.J., Strating J., van Kuppeveld F.J.M. The life cycle of non-polio enteroviruses and how to target it. Nat. Rev. Microbiol. 2018;16:368–381. doi: 10.1038/s41579-018-0005-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0005-4</ArticleId><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Tschope C., Ammirati E., Bozkurt B., Caforio A.L.P., Cooper L.T., Felix S.B., Hare J.M., Heidecker B., Heymans S., Hubner N., et al. Myocarditis and inflammatory cardiomyopathy: Current evidence and future directions. Nat. Rev. Cardiol. 2021;18:169–193. doi: 10.1038/s41569-020-00435-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-00435-x</ArticleId><ArticleId IdType="pmc">PMC7548534</ArticleId><ArticleId IdType="pubmed">33046850</ArticleId></ArticleIdList></Reference><Reference><Citation>Esfandiarei M., McManus B.M. Molecular biology and pathogenesis of viral myocarditis. Annu. Rev. Pathol. 2008;3:127–155. doi: 10.1146/annurev.pathmechdis.3.121806.151534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.pathmechdis.3.121806.151534</ArticleId><ArticleId IdType="pubmed">18039131</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhl U., Pauschinger M., Schwimmbeck P.L., Seeberg B., Lober C., Noutsias M., Poller W., Schultheiss H.P. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation. 2003;107:2793–2798. doi: 10.1161/01.CIR.0000072766.67150.51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000072766.67150.51</ArticleId><ArticleId IdType="pubmed">12771005</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinkert S., Kopp A., Bruckner V., Fechner H., Beling A. Single-Point Mutations within the Coxsackie B Virus Receptor-Binding Site Promote Resistance against Soluble Virus Receptor Traps. J. Virol. 2020;94 doi: 10.1128/JVI.00952-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00952-20</ArticleId><ArticleId IdType="pmc">PMC7495374</ArticleId><ArticleId IdType="pubmed">32669334</ArticleId></ArticleIdList></Reference><Reference><Citation>Garmaroudi F.S., Marchant D., Hendry R., Luo H., Yang D., Ye X., Shi J., McManus B.M. Coxsackievirus B3 replication and pathogenesis. Future Med. 2015;10:629–653. doi: 10.2217/fmb.15.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.15.5</ArticleId><ArticleId IdType="pubmed">25865198</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Zhao S., Chen Y., Wang T., Dong C., Wo X., Zhang J., Dong Y., Xu W., Feng X., et al. The Capsid Protein VP1 of Coxsackievirus B Induces Cell Cycle Arrest by Up-Regulating Heat Shock Protein 70. Front. Microbiol. 2019;10:1633. doi: 10.3389/fmicb.2019.01633.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.01633</ArticleId><ArticleId IdType="pmc">PMC6653663</ArticleId><ArticleId IdType="pubmed">31379784</ArticleId></ArticleIdList></Reference><Reference><Citation>Leveque N., Garcia M., Bouin A., Nguyen J.H.C., Tran G.P., Andreoletti L., Semler B.L. Functional Consequences of RNA 5′-Terminal Deletions on Coxsackievirus B3 RNA Replication and Ribonucleoprotein Complex Formation. J. Virol. 2017;91 doi: 10.1128/JVI.00423-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00423-17</ArticleId><ArticleId IdType="pmc">PMC5533909</ArticleId><ArticleId IdType="pubmed">28539455</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekoua M.P., Alidjinou E.K., Hober D. Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus. Nat. Rev. Endocrinol. 2022;18:503–516. doi: 10.1038/s41574-022-00688-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-022-00688-1</ArticleId><ArticleId IdType="pmc">PMC9157043</ArticleId><ArticleId IdType="pubmed">35650334</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascal S.M., Garimella R., Warden M.S., Ponniah K. Structural Biology of the Enterovirus Replication-Linked 5′-Cloverleaf RNA and Associated Virus Proteins. Microbiol. Mol. Biol. Rev. 2020;84 doi: 10.1128/MMBR.00062-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00062-19</ArticleId><ArticleId IdType="pmc">PMC7399744</ArticleId><ArticleId IdType="pubmed">32188627</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson P.J., Hossain A.R., Qiu Y., Zhang H.M., Zhao G., Li C., Lin V., Sulaimon S., Vlok M., Fung G., et al. Cleavage and Sub-Cellular Redistribution of Nuclear Pore Protein 98 by Coxsackievirus B3 Protease 2A Impairs Cardioprotection. Front. Cell. Infect. Microbiol. 2019;9:265. doi: 10.3389/fcimb.2019.00265.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2019.00265</ArticleId><ArticleId IdType="pmc">PMC6667557</ArticleId><ArticleId IdType="pubmed">31396490</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H., Fung G., Qiu Y., Wang C., Zhang J., Jin Z.G., Luo H. Cleavage of Grb2-Associated Binding Protein 2 by Viral Proteinase 2A during Coxsackievirus Infection. Front. Cell. Infect. Microbiol. 2017;7:85. doi: 10.3389/fcimb.2017.00085.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2017.00085</ArticleId><ArticleId IdType="pmc">PMC5352685</ArticleId><ArticleId IdType="pubmed">28361043</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazina E.V., Smidansky E.D., Holien J.K., Harrison D.N., Cromer B.A., Arnold J.J., Parker M.W., Cameron C.E., Petrou S. Amiloride is a competitive inhibitor of coxsackievirus B3 RNA polymerase. J. Virol. 2011;85:10364–10374. doi: 10.1128/JVI.05022-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05022-11</ArticleId><ArticleId IdType="pmc">PMC3196452</ArticleId><ArticleId IdType="pubmed">21795353</ArticleId></ArticleIdList></Reference><Reference><Citation>Delorme-Axford E., Morosky S., Bomberger J., Stolz D.B., Jackson W.T., Coyne C.B. BPIFB3 regulates autophagy and coxsackievirus B replication through a noncanonical pathway independent of the core initiation machinery. mBio. 2014;5:e02147. doi: 10.1128/mBio.02147-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02147-14</ArticleId><ArticleId IdType="pmc">PMC4324245</ArticleId><ArticleId IdType="pubmed">25491355</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawaged S., Mota T., Piplani H., Thakur R., Lall D., McCabe E., Seo S., Sutterwala F.S., Feuer R., Gottlieb R.A., et al. TBK1 and GABARAP family members suppress Coxsackievirus B infection by limiting viral production and promoting autophagic degradation of viral extracellular vesicles. PLoS Pathog. 2022;18:e1010350. doi: 10.1371/journal.ppat.1010350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010350</ArticleId><ArticleId IdType="pmc">PMC9469980</ArticleId><ArticleId IdType="pubmed">36044516</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Zhao S., Chen Y., Wang Y., Wang T., Wo X., Dong Y., Zhang J., Xu W., Qu C., et al. N-Acetyl cysteine effectively alleviates Coxsackievirus B-Induced myocarditis through suppressing viral replication and inflammatory response. Antivir. Res. 2020;179:104699. doi: 10.1016/j.antiviral.2019.104699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2019.104699</ArticleId><ArticleId IdType="pubmed">31883926</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T., Tu S., Ding L., Jin M., Chen H., Zhou H. The role of autophagy in viral infections. J. Biomed. Sci. 2023;30:5. doi: 10.1186/s12929-023-00899-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-023-00899-2</ArticleId><ArticleId IdType="pmc">PMC9846652</ArticleId><ArticleId IdType="pubmed">36653801</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Yue J. The interplay of autophagy and enterovirus. Semin. Cell Dev. Biol. 2020;101:12–19. doi: 10.1016/j.semcdb.2019.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.08.001</ArticleId><ArticleId IdType="pmc">PMC7102577</ArticleId><ArticleId IdType="pubmed">31563390</ArticleId></ArticleIdList></Reference><Reference><Citation>Corona Velazquez A., Corona A.K., Klein K.A., Jackson W.T. Poliovirus induces autophagic signaling independent of the ULK1 complex. Autophagy. 2018;14:1201–1213. doi: 10.1080/15548627.2018.1458805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2018.1458805</ArticleId><ArticleId IdType="pmc">PMC6103675</ArticleId><ArticleId IdType="pubmed">29929428</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi X., Chen Z., Tang S., Wu F., Xiong S., Dong C. Coxsackievirus B3 infection induces autophagic flux, and autophagosomes are critical for efficient viral replication. Arch. Virol. 2016;161:2197–2205. doi: 10.1007/s00705-016-2896-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-016-2896-6</ArticleId><ArticleId IdType="pubmed">27224983</ArticleId></ArticleIdList></Reference><Reference><Citation>Glick D., Barth S., Macleod K.F. Autophagy: Cellular and molecular mechanisms. J. Pathol. 2010;221:3–12. doi: 10.1002/path.2697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.2697</ArticleId><ArticleId IdType="pmc">PMC2990190</ArticleId><ArticleId IdType="pubmed">20225336</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N., Komatsu M. Autophagy: Renovation of cells and tissues. Cell. 2011;147:728–741. doi: 10.1016/j.cell.2011.10.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.10.026</ArticleId><ArticleId IdType="pubmed">22078875</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine B., Kroemer G. Biological Functions of Autophagy Genes: A Disease Perspective. Cell. 2019;176:11–42. doi: 10.1016/j.cell.2018.09.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.09.048</ArticleId><ArticleId IdType="pmc">PMC6347410</ArticleId><ArticleId IdType="pubmed">30633901</ArticleId></ArticleIdList></Reference><Reference><Citation>Marquardt L., Taylor M., Kramer F., Schmitt K., Braus G.H., Valerius O., Thumm M. Vacuole fragmentation depends on a novel Atg18-containing retromer-complex. Autophagy. 2023;19:278–295. doi: 10.1080/15548627.2022.2072656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2022.2072656</ArticleId><ArticleId IdType="pmc">PMC9809942</ArticleId><ArticleId IdType="pubmed">35574911</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua J.P., De Calbiac H., Kabashi E., Barmada S.J. Autophagy and ALS: Mechanistic insights and therapeutic implications. Autophagy. 2022;18:254–282. doi: 10.1080/15548627.2021.1926656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2021.1926656</ArticleId><ArticleId IdType="pmc">PMC8942428</ArticleId><ArticleId IdType="pubmed">34057020</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H.L., Zhu Y.M., Zhou X.Y. Coordination of Autophagy and Other Cellular Activities. Adv. Exp. Med. Biol. 2019;1206:697–727.</Citation><ArticleIdList><ArticleId IdType="pubmed">31777007</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X., Elfimova N., Muller M., Bachurski D., Koitzsch U., Drebber U., Mahabir E., Hansen H.P., Friedman S.L., Klein S., et al. Autophagy-Related Activation of Hepatic Stellate Cells Reduces Cellular miR-29a by Promoting Its Vesicular Secretion. Cell. Mol. Gastroenterol. Hepatol. 2022;13:1701–1716. doi: 10.1016/j.jcmgh.2022.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmgh.2022.02.013</ArticleId><ArticleId IdType="pmc">PMC9046234</ArticleId><ArticleId IdType="pubmed">35219894</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbini Dhouib I., Jallouli M., Annabi A., Gharbi N., Elfazaa S., Lasram M.M. A minireview on N-acetylcysteine: An old drug with new approaches. Life Sci. 2016;151:359–363. doi: 10.1016/j.lfs.2016.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2016.03.003</ArticleId><ArticleId IdType="pubmed">26946308</ArticleId></ArticleIdList></Reference><Reference><Citation>Nocito Echevarria M.A., Andrade Reis T., Ruffo Capatti G., Siciliano Soares V., da Silveira D.X., Fidalgo T.M. N-acetylcysteine for treating cocaine addiction—A systematic review. Psychiatry Res. 2017;251:197–203. doi: 10.1016/j.psychres.2017.02.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2017.02.024</ArticleId><ArticleId IdType="pubmed">28213190</ArticleId></ArticleIdList></Reference><Reference><Citation>Geiler J., Michaelis M., Naczk P., Leutz A., Langer K., Doerr H.W., Cinatl J., Jr. N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus. Biochem. Pharmacol. 2010;79:413–420. doi: 10.1016/j.bcp.2009.08.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2009.08.025</ArticleId><ArticleId IdType="pubmed">19732754</ArticleId></ArticleIdList></Reference><Reference><Citation>Pani A., Marongiu M.E., La Colla P. Modulatory effect of N-acetyl-L-cysteine on the HIV-1 multiplication in chronically and acutely infected cell lines. Antivir. Res. 1993;22:31–43. doi: 10.1016/0166-3542(93)90084-V.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0166-3542(93)90084-V</ArticleId><ArticleId IdType="pubmed">8250542</ArticleId></ArticleIdList></Reference><Reference><Citation>Izquierdo-Alonso J.L., Perez-Rial S., Rivera C.G., Peces-Barba G. N-acetylcysteine for prevention and treatment of COVID-19: Current state of evidence and future directions. J. Infect. Public Health. 2022;15:1477–1483. doi: 10.1016/j.jiph.2022.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2022.11.009</ArticleId><ArticleId IdType="pmc">PMC9651994</ArticleId><ArticleId IdType="pubmed">36410267</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Wang C., Yan F., Wang T., He Y., Li H., Xia Z., Zhang Z. N-Acetylcysteine Attenuates Diabetic Myocardial Ischemia Reperfusion Injury through Inhibiting Excessive Autophagy. Mediat. Inflamm. 2017;2017:9257291. doi: 10.1155/2017/9257291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/9257291</ArticleId><ArticleId IdType="pmc">PMC5317145</ArticleId><ArticleId IdType="pubmed">28265179</ArticleId></ArticleIdList></Reference><Reference><Citation>He F., Zheng G., Hou J., Hu Q., Ling Q., Wu G., Zhao H., Yang J., Wang Y., Jiang L., et al. N-acetylcysteine alleviates post-resuscitation myocardial dysfunction and improves survival outcomes via partly inhibiting NLRP3 inflammasome induced-pyroptosis. J. Inflamm. 2020;17:25. doi: 10.1186/s12950-020-00255-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12950-020-00255-3</ArticleId><ArticleId IdType="pmc">PMC7409674</ArticleId><ArticleId IdType="pubmed">32782443</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei C., Yang J., Hu J., Sun X. On the Calculation of TCID(50) for Quantitation of Virus Infectivity. Virol. Sin. 2021;36:141–144. doi: 10.1007/s12250-020-00230-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-020-00230-5</ArticleId><ArticleId IdType="pmc">PMC7973348</ArticleId><ArticleId IdType="pubmed">32458296</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateyak M.K., Kinzy T.G. eEF1A: Thinking outside the ribosome. J. Biol. Chem. 2010;285:21209–21213. doi: 10.1074/jbc.R110.113795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R110.113795</ArticleId><ArticleId IdType="pmc">PMC2898402</ArticleId><ArticleId IdType="pubmed">20444696</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasikumar A.N., Perez W.B., Kinzy T.G. The many roles of the eukaryotic elongation factor 1 complex. Wiley Interdiscip. Rev. RNA. 2012;3:543–555. doi: 10.1002/wrna.1118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1118</ArticleId><ArticleId IdType="pmc">PMC3374885</ArticleId><ArticleId IdType="pubmed">22555874</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikora D., Greco-Stewart V.S., Miron P., Pelchat M. The hepatitis delta virus RNA genome interacts with eEF1A1, p54(nrb), hnRNP-L, GAPDH and ASF/SF2. Virology. 2009;390:71–78. doi: 10.1016/j.virol.2009.04.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2009.04.022</ArticleId><ArticleId IdType="pubmed">19464723</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao E., Zhao S., Dong Y., Wang Y., Fei Y., Li S., Wang L., Bashir T., Luan T., Lin L., et al. Anisomycin inhibits Coxsackievirus B replication by promoting the lysosomal degradation of eEF1A1. Antivir. Res. 2023;215:105621. doi: 10.1016/j.antiviral.2023.105621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2023.105621</ArticleId><ArticleId IdType="pubmed">37156267</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalyfa A., Bourbeau D., Chen E., Petroulakis E., Pan J., Xu S., Wang E. Characterization of elongation factor-1A (eEF1A-1) and eEF1A-2/S1 protein expression in normal and wasted mice. J. Biol. Chem. 2001;276:22915–22922. doi: 10.1074/jbc.M101011200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M101011200</ArticleId><ArticleId IdType="pubmed">11294870</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies F.C.J., Marshall G.F., Pegram E., Gadd D., Abbott C.M. Endogenous epitope tagging of eEF1A2 in mice reveals early embryonic expression of eEF1A2 and subcellular compartmentalisation of neuronal eEF1A1 and eEF1A2. Mol. Cell. Neurosci. 2023;126:103879. doi: 10.1016/j.mcn.2023.103879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2023.103879</ArticleId><ArticleId IdType="pubmed">37429391</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Geng Z., Yang C., Zhou H., Wang Y., Kuerban B., Luo G. Effect of N-acetyl-l-cysteine on Cell Phenotype and Autophagy in Pichia pastoris Expressing Human Serum Albumin and Porcine Follicle-Stimulating Hormone Fusion Protein. Molecules. 2023;28:3041. doi: 10.3390/molecules28073041.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules28073041</ArticleId><ArticleId IdType="pmc">PMC10095845</ArticleId><ArticleId IdType="pubmed">37049804</ArticleId></ArticleIdList></Reference><Reference><Citation>Inobe T., Matouschek A. Paradigms of protein degradation by the proteasome. Curr. Opin. Struct. Biol. 2014;24:156–164. doi: 10.1016/j.sbi.2014.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2014.02.002</ArticleId><ArticleId IdType="pmc">PMC4010099</ArticleId><ArticleId IdType="pubmed">24632559</ArticleId></ArticleIdList></Reference><Reference><Citation>Jassey A., Wagner M.A., Galitska G., Paudel B., Miller K., Jackson W.T. Starvation after infection restricts enterovirus D68 replication. Autophagy. 2023;19:112–125. doi: 10.1080/15548627.2022.2062888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2022.2062888</ArticleId><ArticleId IdType="pmc">PMC9809931</ArticleId><ArticleId IdType="pubmed">35446171</ArticleId></ArticleIdList></Reference><Reference><Citation>Goruppi S., Jo S.H., Laszlo C., Clocchiatti A., Neel V., Dotto G.P. Autophagy Controls CSL/RBPJkappa Stability through a p62/SQSTM1-Dependent Mechanism. Cell Rep. 2018;24:3108–3114.e4. doi: 10.1016/j.celrep.2018.08.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.08.043</ArticleId><ArticleId IdType="pmc">PMC6200139</ArticleId><ArticleId IdType="pubmed">30231994</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhl U., Lassner D., von Schlippenbach J., Poller W., Schultheiss H.P. Interferon-Beta improves survival in enterovirus-associated cardiomyopathy. J. Am. Coll. Cardiol. 2012;60:1295–1296. doi: 10.1016/j.jacc.2012.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2012.06.026</ArticleId><ArticleId IdType="pubmed">23017536</ArticleId></ArticleIdList></Reference><Reference><Citation>Calverley P., Rogliani P., Papi A. Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A Review. Drug Saf. 2021;44:273–290. doi: 10.1007/s40264-020-01026-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-020-01026-y</ArticleId><ArticleId IdType="pmc">PMC7892733</ArticleId><ArticleId IdType="pubmed">33326056</ArticleId></ArticleIdList></Reference><Reference><Citation>Matera M.G., Calzetta L., Cazzola M. Oxidation pathway and exacerbations in COPD: The role of NAC. Expert Rev. Respir. Med. 2016;10:89–97. doi: 10.1586/17476348.2016.1121105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/17476348.2016.1121105</ArticleId><ArticleId IdType="pubmed">26567752</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Liao J., Chen W., Zhang K., Li H., Ma F., Zhang H., Han Q., Guo J., Li Y., et al. NAC alleviative ferroptosis in diabetic nephropathy via maintaining mitochondrial redox homeostasis through activating SIRT3-SOD2/Gpx4 pathway. Free Radic. Biol. Med. 2022;187:158–170. doi: 10.1016/j.freeradbiomed.2022.05.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2022.05.024</ArticleId><ArticleId IdType="pubmed">35660452</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills A., Gago F. On the Need to Tell Apart Fraternal Twins eEF1A1 and eEF1A2, and Their Respective Outfits. Int. J. Mol. Sci. 2021;22:6973. doi: 10.3390/ijms22136973.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22136973</ArticleId><ArticleId IdType="pmc">PMC8268798</ArticleId><ArticleId IdType="pubmed">34203525</ArticleId></ArticleIdList></Reference><Reference><Citation>Lisy S., Rothamel K., Ascano M. RNA Binding Proteins as Pioneer Determinants of Infection: Protective, Proviral, or Both? Viruses. 2021;13:2172. doi: 10.3390/v13112172.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13112172</ArticleId><ArticleId IdType="pmc">PMC8625426</ArticleId><ArticleId IdType="pubmed">34834978</ArticleId></ArticleIdList></Reference><Reference><Citation>Francisco-Velilla R., Embarc-Buh A., Abellan S., Martinez-Salas E. Picornavirus translation strategies. FEBS Open Bio. 2022;12:1125–1141. doi: 10.1002/2211-5463.13400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/2211-5463.13400</ArticleId><ArticleId IdType="pmc">PMC9157412</ArticleId><ArticleId IdType="pubmed">35313388</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr J.M., Kua T., Clarke J.N., Calvert J.K., Zebol J.R., Beard M.R., Pitson S.M. Reduced sphingosine kinase 1 activity in dengue virus type-2 infected cells can be mediated by the 3′ untranslated region of dengue virus type-2 RNA. Pt 11J. Gen. Virol. 2013;94:2437–2448. doi: 10.1099/vir.0.055616-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.055616-0</ArticleId><ArticleId IdType="pubmed">23939980</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Wei T., Abbott C.M., Harrich D. The unexpected roles of eukaryotic translation elongation factors in RNA virus replication and pathogenesis. Microbiol. Mol. Biol. Rev. 2013;77:253–266. doi: 10.1128/MMBR.00059-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00059-12</ArticleId><ArticleId IdType="pmc">PMC3668672</ArticleId><ArticleId IdType="pubmed">23699257</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan H., Zhou X., Lei Q., Wu L., Niu J., Zheng Q. RNA-dependent RNA polymerase of SARS-CoV-2 regulate host mRNA translation efficiency by hijacking eEF1A factors. Biochim. Biophys. Acta (BBA)—Mol. Basis Dis. 2024;1870:166871. doi: 10.1016/j.bbadis.2023.166871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2023.166871</ArticleId><ArticleId IdType="pubmed">37673357</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Rawle D.J., Wu Z., Jin H., Lin M.H., Lor M., Abbott C.M., Harrich D. eEF1A demonstrates paralog specific effects on HIV-1 reverse transcription efficiency. Virology. 2019;530:65–74. doi: 10.1016/j.virol.2019.01.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2019.01.023</ArticleId><ArticleId IdType="pubmed">30782564</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H., Green D.R., Zou W. Autophagy in tumour immunity and therapy. Nat. Rev. Cancer. 2021;21:281–297. doi: 10.1038/s41568-021-00344-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41568-021-00344-2</ArticleId><ArticleId IdType="pmc">PMC8087647</ArticleId><ArticleId IdType="pubmed">33758415</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Ren Q., Zhang J., Ye Y., Zhang Z., Xu Y., Guo M., Ji H., Xu C., Gu C., et al. N-acetyl-L-cysteine protects against cadmium-induced neuronal apoptosis by inhibiting ROS-dependent activation of Akt/mTOR pathway in mouse brain. Neuropathol. Appl. Neurobiol. 2014;40:759–777. doi: 10.1111/nan.12103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12103</ArticleId><ArticleId IdType="pmc">PMC4043941</ArticleId><ArticleId IdType="pubmed">24299490</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Z.W., Hanczko R., Bonilla E., Caza T.N., Clair B., Bartos A., Miklossy G., Jimah J., Doherty E., Tily H., et al. N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2012;64:2937–2946. doi: 10.1002/art.34502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34502</ArticleId><ArticleId IdType="pmc">PMC3411859</ArticleId><ArticleId IdType="pubmed">22549432</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M.Y., Zhu X.L., Zhao B.X., Shi L., Wang W., Hu W., Qin S.L., Chen B.H., Zhou P.H., Qiu B., et al. Adrenomedullin alleviates the pyroptosis of Leydig cells by promoting autophagy via the ROS-AMPK-mTOR axis. Cell Death Dis. 2019;10:489. doi: 10.1038/s41419-019-1728-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1728-5</ArticleId><ArticleId IdType="pmc">PMC6586845</ArticleId><ArticleId IdType="pubmed">31222000</ArticleId></ArticleIdList></Reference><Reference><Citation>Pankiv S., Clausen T.H., Lamark T., Brech A., Bruun J.A., Outzen H., Overvatn A., Bjorkoy G., Johansen T. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 2007;282:24131–24145. doi: 10.1074/jbc.M702824200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M702824200</ArticleId><ArticleId IdType="pubmed">17580304</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J., Pang X., Zhang X., Qiu W., Zhang X., Wang R., Xie W., Bai Y., Zhou S., Liao J., et al. N-acetylcysteine combined with insulin attenuates myocardial injury in canines with type 1 diabetes mellitus by modulating TNF-alpha-mediated apoptotic pathways and affecting linear ubiquitination. Transl. Res. 2023;262:1–11. doi: 10.1016/j.trsl.2023.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2023.07.003</ArticleId><ArticleId IdType="pubmed">37422055</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>